Mitoxantrone hydrochloride
- Level
- Commodity
- Parent
- 51281800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281823This classification denotes an anthracenedione-derived antineoplastic agent, analgesic, and anthraquinone with the molecular formula C22H28N4O6.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U6USW86RD0, chemically known as 9,10-anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9ci) but more generally known as mitoxantrone hydrochloride, which bears US NIH Compound Identifier 4212. European Medicines Agency schedules Mitoxantrone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03309MIG. Most nations, for tariff and trade purposes, schedule mitoxantrone hydrochloride under HS 29225000 and SITC 51467. As of Q4 2014, MITOXANTRONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Mitoxantrone hydrochloride bears US NLM identifiers UMLS ID C1513359 and NCI Concept Code C665. SMILES: C1CC(C2C(C1NCCNCCO)C(=O)C3C(CCC(C3C2=O)O)O)NCCNCCO.CL.CL.
Same parent
Under 51281800 · 24Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.